908 Devices Inc.MASSEarnings & Financial Report
908 Devices Inc. develops and manufactures portable, high-performance mass spectrometry devices and analytical solutions. Its products serve use cases across life science research, biopharmaceutical manufacturing, public safety, forensics, and industrial process monitoring, catering to global customers including research institutions, pharmaceutical firms and government agencies.
Revenue
$11.5M
Gross Profit
$6.2M
Operating Profit
$-8.5M
Net Profit
$-12.5M
Gross Margin
53.8%
Operating Margin
-74.5%
Net Margin
-109.5%
YoY Growth
-5.2%
EPS
$-0.37
908 Devices Inc. Q2 FY2024 Financial Summary
908 Devices Inc. reported revenue of $11.5M (down 5.2% YoY) for Q2 FY2024, with a net profit of $-12.5M (down 34.3% YoY) (-109.5% margin). Cost of goods sold was $5.3M, operating expenses totaled $14.7M.
Key Financial Metrics
| Total Revenue | $11.5M |
|---|---|
| Net Profit | $-12.5M |
| Gross Margin | 53.8% |
| Operating Margin | -74.5% |
| Report Period | Q2 FY2024 |
Revenue Breakdown
908 Devices Inc. Q2 FY2024 revenue of $11.5M breaks down across 2 segments, led by Products at $10.3M (89.6% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Products | $10.3M | 89.6% |
| Other | $1.2M | 10.4% |
908 Devices Inc. Revenue by Segment — Quarterly Trend
908 Devices Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Products and Other) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Products | $14.3M | — | — | $8.5M |
908 Devices Inc. Annual Revenue by Year
908 Devices Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $56.2M).
| Year | Annual Revenue |
|---|---|
| 2025 | $56.2M |
| 2024 | $47.7M |
| 2023 | $50.2M |
| 2022 | $46.9M |
908 Devices Inc. Quarterly Revenue & Net Profit History
908 Devices Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $17.4M | +21.2% | $4.2M | 24.0% |
| Q3 FY2025 | $14.0M | -3.5% | $-15.0M | -107.0% |
| Q2 FY2025 | $13.0M | +13.7% | $-13.3M | -102.1% |
| Q1 FY2025 | $11.8M | +58.7% | $43.6M | 370.2% |
| Q4 FY2024 | $14.3M | -0.1% | $-19.4M | -135.6% |
| Q3 FY2024 | $14.5M | +1.6% | $-29.3M | -201.8% |
| Q2 FY2024 | $11.5M | -5.2% | $-12.5M | -109.5% |
| Q1 FY2024 | $7.4M | -21.8% | $-10.9M | -147.1% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.4M | $11.5M | $14.5M | $14.3M | $11.8M | $13.0M | $14.0M | $17.4M |
| YoY Growth | -21.8% | -5.2% | 1.6% | -0.1% | 58.7% | 13.7% | -3.5% | 21.2% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $189.8M | $208.8M | $178.3M | $159.5M | $196.0M | $191.7M | $190.9M | $190.1M |
| Liabilities | $32.9M | $52.4M | $47.2M | $44.9M | $36.6M | $42.9M | $54.6M | $46.4M |
| Equity | $156.9M | $156.4M | $131.0M | $114.6M | $159.4M | $148.8M | $136.3M | $143.7M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-9.4M | $-13.0M | $-5.6M | $-2.2M | $-15.0M | $-5.8M | $-4.2M | $1.3M |